DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY
DEAD

Serial Number

98935691

Owner

Replimune Limited

Attorney

Melanie Howard

Filing Date

Jan 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY Trademark

Serial Number: 98935691

DEVELOPING THE 'ON' SWITCH FOR IMMUNO-ONCOLOGY is a trademark filed by Replimune Limited on January 3, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Replimune Limited (14 trademarks)

69 Innovation Dr., Milton Park, Abingdon
Oxfordshire OX144RQ , GB

Entity Type: 99

Trademark Details

Filing Date

January 3, 2025

Registration Date

Not Registered

Published for Opposition

August 5, 2025

Goods & Services

Biological preparations in the nature of viruses for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; biological preparations in the nature of viruses for the treatment of cancer; biological preparations in the nature of viruses for inducing immune response; pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical substances for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for inducing immune response; vaccines; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders

Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 4, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 4, 2026 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 30, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2025 CNSA
ASSIGNED TO EXAMINER
Jun 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2025 NWOS
NEW APPLICATION ENTERED
Jan 3, 2025 NWAP